as on February 4, 2026 at 2:29 am IST
Day's Low
Day's High
1.27%
Downside
4.91%
Upside
52 Week's Low
52 Week's High
24.47%
Downside
30.16%
Upside
Check Dexcom, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$28.9B
EPS (TTM)
2.0671
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
1.10%
PE Ratio (TTM)
40.93
Industry PE ratio
22.568026315789474
PEG Ratio
1.0826
EBITDA
1.0B
Revenue (TTM)
4.5B
Profit Margin
15.96%
Return On Equity TTM
30.64%
Track how Dexcom, Inc. P/E has moved over time to understand its valuation trends.
Dexcom, Inc. in the last 5 years
Lowest (44.21x)
September 30, 2025
Industry (22.57x)
February 4, 2026
Today (40.93x)
February 4, 2026
Highest (175.15x)
September 30, 2021
Today’s Price to Earnings Ratio: 40.93x
Compare market cap, revenue, PE, and other key metrics of Dexcom, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $28.9B | -28.95% | 40.93 | 15.96% | |
| BUY | $138.7B | 136.38% | 50.03 | 14.43% | |
| BUY | $136.5B | 52.19% | 46.97 | 12.07% | |
| BUY | $129.1B | -11.81% | 27.28 | 13.71% | |
| BUY | $49.1B | -3.9% | 36.83 | 23.25% |
The Dexcom, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Dexcom, Inc. investment value today
Current value as on today
₹85,649
Returns
Returns from Dexcom, Inc. Stock
Dollar Returns*
₹3,737 (+3.74%)
Based on 30 analysts
86.67%
Buy
13.33%
Hold
0.00%
Sell
Based on 30 analysts, 86.67% of analysts recommend a 'BUY' rating for Dexcom, Inc.. Average target price of $85.19
Get share price movements and forecasts by analysts on Dexcom, Inc..
What analysts predicted
15.91%UPSIDE
Target Price
$85.19
Current Price
$71.64
Analyzed by
30 Analysts
Target
$85.19
Dexcom, Inc. target price $85.19, a slight upside of 15.91% compared to current price of $71.64. According to 30 analysts rating.
Search interest for Dexcom, Inc. Stock has increased by 20% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:20%Â versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 12 January
Mon, 06:01 PM
-Dexcom reports preliminary Q4 2025 results, forecasting 2026 revenue growth of 11-13%.
Mon, 10:41 PM
-Shares of Dexcom rose over 5% after announcing Q4 results and 2026 revenue forecast.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Dexcom, Inc. has shown strong profit growth over the last three quarters. The company's net profit increased from $105.4 million to $283.8 million, which reflects an average growth of 39.0% each quarter.
Revenue Rich
![]()
Dexcom, Inc. has shown positive revenue growth over the last three quarters. Revenue increased from $1.03 billion to $1.20 billion, reflecting an average increase of 7.4% per quarter.
Price Rise
![]()
In the last 3 months, DXCM stock has moved up by 17.1%
Against Peers
![]()
In the last 1 year, Edwards Lifesciences Corp. has given 15.1% return, outperforming this stock by 33.2%
Against Peers
![]()
In the last 3 years, Boston Scientific Corp. has given 0.0% return, outperforming this stock by 33.9%
| Organisation | Dexcom, Inc. |
| Headquarters | 6340 Sequence Drive, San Diego, CA, United States, 92121 |
| Industry | Health Technology |
| CEO | Mr. Jacob Steven Leach |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Kevin Ronald Sayer | Executive Chairman of the Board (Leave of Absence) |
Mr. Jereme M. Sylvain CPA | Executive VP, CFO & Chief Accounting Officer |
Mr. Michael Jon Brown | Executive VP & Chief Legal Officer |
Ms. Sadie M. Stern | Executive VP & Chief Human Resources Officer |
Mr. Sean Christensen | Vice President of Finance and Investor Relations |
Mr. Jacob Steven Leach | President, CEO & Director |
Mr. Girish Naganathan | Executive VP & CTO |
Mr. Matthew Dolan | Executive Vice President of Strategy & Corporate Development |
Mr. Donald M. Abbey | Executive Vice President of Global Business Services, Regulatory, Medical & Clinical Affairs |
Mr. Jon Coleman | Executive VP & Chief Commercial Officer |
Dexcom, Inc. share price today is $71.64 as on at the close of the market. Dexcom, Inc. share today touched a day high of $75.16 and a low of $70.73.
Dexcom, Inc. share touched a 52 week high of $93.25 on and a 52 week low of $54.11 on . Dexcom, Inc. stock price today i.e. is closed at $71.64,which is 23.17% down from its 52 week high and 32.40% up from its 52 week low.
Dexcom, Inc. market capitalisation is $0.03T as on .
Indian investors can start investing in Dexcom, Inc. (DXCM) shares with as little as ₹90.22 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹902.20 in Dexcom, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Dexcom, Inc. share’s latest price of $71.64 as on February 4, 2026 at 2:29 am IST, you will get 0.1396 shares of Dexcom, Inc.. Learn more about
fractional shares .
Dexcom, Inc. stock has given -28.95% share price returns and 25.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?